
Ovarian Cancer — Year in Review Series on Relevant New Datasets and Advances
Oncology Today with Dr Neil Love
00:00
Frontline PARP strategy and HRD testing
Kathleen reviews frontline PARP use for HRD-positive tumors and the need for reliable tumor testing at diagnosis.
Play episode from 41:49
Transcript


